Skip Navigation
Skip to contents

Ann Coloproctol : Annals of Coloproctology

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
1 "Gastrointestinal microbiome"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Review
Differences Regarding the Molecular Features and Gut Microbiota Between Right and Left Colon Cancer
Kwangmin Kim, Ernes John T. Castro, Hongjin Shim, John Vincent G. Advincula, Young-Wan Kim
Ann Coloproctol. 2018;34(6):280-285.   Published online December 31, 2018
DOI: https://doi.org/10.3393/ac.2018.12.17
  • 7,905 View
  • 266 Download
  • 41 Web of Science
  • 39 Citations
AbstractAbstract PDF
For many years, developmental and physiological differences have been known to exist between anatomic segments of the colorectum. Because of different outcomes, prognoses, and clinical responses to chemotherapy, the distinction between right colon cancer (RCC) and left colon cancer (LCC) has gained attention. Furthermore, variations in the molecular features and gut microbiota between right and LCCs have recently been a hot research topic. CpG island methylator phenotype-high, microsatellite instability-high colorectal cancers are more likely to occur on the right side whereas tumors with chromosomal instability have been detected in approximately 75% of LCC patients and 30% of RCC patients. The mutation rates of oncogenes and tumor suppressor genes also differ between RCC and LCC patients. Biofilm is more abundant in RCC patients than LLC patients, as are Prevotella, Selenomonas, and Peptostreptococcus. Conversely, Fusobacterium, Escherichia/Shigella, and Leptotrichia are more abundant in LCC patients compared to RCC patients. Distinctive characteristics are apparent in terms of molecular features and gut microbiota between right and LCC. However, how or to what extent these differences influence diverging oncologic outcomes remains unclear. Further clinical and translational studies are needed to elucidate the causative relationship between primary tumor location and prognosis.

Citations

Citations to this article as recorded by  
  • Integrating E-cadherin expression levels with TNM staging for enhanced prognostic prediction in colorectal cancer patients
    Jae-Ghi Lee, Ilkyu Park, Hannah Lee, Seungyoon Nam, Jisup Kim, Won-Suk Lee, Myunghee Kang, Jung Ho Kim
    BMC Cancer.2025;[Epub]     CrossRef
  • The Gut Microbiota and Colorectal Cancer: Understanding the Link and Exploring Therapeutic Interventions
    Imen Zalila-Kolsi, Dhoha Dhieb, Hussam A. Osman, Hadjer Mekideche
    Biology.2025; 14(3): 251.     CrossRef
  • The gut microbiota and its biogeography
    Giselle McCallum, Carolina Tropini
    Nature Reviews Microbiology.2024; 22(2): 105.     CrossRef
  • The role of gut microbiota and probiotics in preventing, treating, and boosting the immune system in colorectal cancer
    Forough Masheghati, Mohammad Reza Asgharzadeh, Abbas Jafari, Naser Masoudi, Hadi Maleki-Kakelar
    Life Sciences.2024; 344: 122529.     CrossRef
  • Diet-mediated gut microbial community modulation and signature metabolites as potential biomarkers for early diagnosis, prognosis, prevention and stage-specific treatment of colorectal cancer
    Mutebi John Kenneth, Hsin-Chi Tsai, Chuan-Yin Fang, Bashir Hussain, Yi-Chou Chiu, Bing-Mu Hsu
    Journal of Advanced Research.2023; 52: 45.     CrossRef
  • Microbiome and metabolic features of tissues and feces reveal diagnostic biomarkers for colorectal cancer
    Jiahui Feng, Zhizhong Gong, Zhangran Sun, Juan Li, Na Xu, Rick F. Thorne, Xu Dong Zhang, Xiaoying Liu, Gang Liu
    Frontiers in Microbiology.2023;[Epub]     CrossRef
  • Metachronous Colorectal Adenomas Occur Close to the Index Lesion
    Ria Rosser, Bernard M. Corfe, Keith S. Chapple
    Journal of Clinical Gastroenterology.2023; 57(9): 937.     CrossRef
  • Genetic heterogeneity of colorectal cancer and the microbiome
    Marina A Senchukova
    World Journal of Gastrointestinal Oncology.2023; 15(3): 443.     CrossRef
  • Impact of Colorectal Cancer Sidedness and Location on Therapy and Clinical Outcomes: Role of Blood-Based Biopsy for Personalized Treatment
    Sasha Waldstein, Marianne Spengler, Iryna V. Pinchuk, Nelson S. Yee
    Journal of Personalized Medicine.2023; 13(7): 1114.     CrossRef
  • Fusobacterium nucleatum-Mediated Alteration in Expression of VEGF and CCL3 Genes and KRAS Mutation in Colorectal Cancer Patients
    Hataw Jalal Taher, Fouad Kamel
    Jundishapur Journal of Microbiology.2023;[Epub]     CrossRef
  • Risk of developing metachronous colorectal neoplasia after the resection of proximal versus distal adenomas
    Yoon Suk Jung, Nam Hee Kim, Youngwoo Kim, Dong Il Park
    Digestive and Liver Disease.2022; 54(4): 537.     CrossRef
  • Faeces from malnourished colorectal cancer patients accelerate cancer progression
    Xu Chao, Zhang Lei, Liu Hongqin, Wang Ziwei, Li Dechuan, Du Weidong, Xu Lu, Chen Haitao, Zhang Bo, Ju Haixing, Yao Qinghua
    Clinical Nutrition.2022; 41(3): 632.     CrossRef
  • Clinical and molecular profile of young adults with early‐onset colorectal cancer: Experience from four Australian tertiary centers
    Derrick Ho Wai Siu, Arwa Ali, Angelina Tjokrowidjaja, Madhawa De Silva, Joanna Lee, Philip R. Clingan, Morteza Aghmesheh, Daniel Brungs, Cristina Mapagu, David Goldstein, Siobhan O'Neill, Winston S. Liauw, Katrin M. Sjoquist, David Thomas, Nick Pavlakis,
    Asia-Pacific Journal of Clinical Oncology.2022; 18(6): 660.     CrossRef
  • Microbial Characteristics of Common Tongue Coatings in Patients with Precancerous Lesions of the Upper Gastrointestinal Tract
    Xiaoyu Kang, Bin Lu, Pan Xiao, Zhaolai Hua, Rui Shen, Jianping Wu, Juan Wu, Zhenfeng Wu, Chun Cheng, Junfeng Zhang, Enas Abdulhay
    Journal of Healthcare Engineering.2022; 2022: 1.     CrossRef
  • Colorectal microbiota after removal of colorectal cancer
    Peter Cronin, Clodagh L Murphy, Maurice Barrett, Tarini Shankar Ghosh, Paola Pellanda, Eibhlis M O’Connor, Syed Akbar Zulquernain, Shane Kileen, Morgan McCourt, Emmet Andrews, Micheal G O’Riordain, Fergus Shanahan, Paul W O’Toole
    NAR Cancer.2022;[Epub]     CrossRef
  • Pretreatment inflammatory markers predicting treatment outcomes in colorectal cancer
    Sanghyun An, Hongjin Shim, Kwangmin Kim, Bora Kim, Hui-Jae Bang, Hyejin Do, Hyang-Rae Lee, Youngwan Kim
    Annals of Coloproctology.2022; 38(2): 97.     CrossRef
  • Tumor tissue-specific bacterial biomarker panel for colorectal cancer: Bacteroides massiliensis, Alistipes species, Alistipes onderdonkii, Bifidobacterium pseudocatenulatum, Corynebacterium appendicis
    Rizwana Hasan, Sudeep Bose, Rahul Roy, Debarati Paul, Saumitra Rawat, Pravin Nilwe, Neeraj K. Chauhan, Sangeeta Choudhury
    Archives of Microbiology.2022;[Epub]     CrossRef
  • Association of tumor-infiltrating lymphocytes with survival depends on primary tumor sidedness in stage III colon cancers (NCCTG N0147) [Alliance]
    B. Saberzadeh-Ardestani, N.R. Foster, H.E. Lee, Q. Shi, S.R. Alberts, T.C. Smyrk, F.A. Sinicrope
    Annals of Oncology.2022; 33(11): 1159.     CrossRef
  • Fecal Luminal Factors from Patients with Gastrointestinal Diseases Alter Gene Expression Profiles in Caco-2 Cells and Colonoids
    Luiza Holst, Cristina Iribarren, Maria Sapnara, Otto Savolainen, Hans Törnblom, Yvonne Wettergren, Hans Strid, Magnus Simrén, Maria K. Magnusson, Lena Öhman
    International Journal of Molecular Sciences.2022; 23(24): 15505.     CrossRef
  • Phosphorylated transducer and activator of transcription-3 (pSTAT3) immunohistochemical expression in paired primary and metastatic colorectal cancer
    Esmeralda C. Marginean, Joanna Gotfrit, Horia Marginean, Daniel W. Yokom, Justin J. Bateman, Manijeh Daneshmand, Shelly Sud, Allen M. Gown, Derek Jonker, Timothy Asmis, Rachel A. Goodwin
    Translational Oncology.2021; 14(2): 100996.     CrossRef
  • Construction of a long noncoding RNA-based competing endogenous RNA network and prognostic signatures of left- and right-side colon cancer
    Ke-zhi Li, Yi-xin Yin, Yan-ping Tang, Long Long, Ming-zhi Xie, Ji-lin Li, Ke Ding, Bang-li Hu
    Cancer Cell International.2021;[Epub]     CrossRef
  • Gut Microbiota as Potential Biomarker and/or Therapeutic Target to Improve the Management of Cancer: Focus on Colibactin-Producing Escherichia coli in Colorectal Cancer
    Julie Veziant, Romain Villéger, Nicolas Barnich, Mathilde Bonnet
    Cancers.2021; 13(9): 2215.     CrossRef
  • Association of Habitual Preoperative Dietary Fiber Intake With Complications After Colorectal Cancer Surgery
    Dieuwertje E. Kok, Melissa N. N. Arron, Tess Huibregtse, Flip M. Kruyt, Dirk Jan Bac, Henk K. van Halteren, Ewout A. Kouwenhoven, Evertine Wesselink, Renate M. Winkels, Moniek van Zutphen, Fränzel J. B. van Duijnhoven, Johannes H. W. de Wilt, Ellen Kampma
    JAMA Surgery.2021; 156(9): 827.     CrossRef
  • Resectable Colorectal Cancer: Current Perceptions on the Correlation of Recurrence Risk, Microbiota and Detection of Genetic Mutations in Liquid Biopsies
    Andreas Koulouris, Christos Tsagkaris, Ippokratis Messaritakis, Nikolaos Gouvas, Maria Sfakianaki, Maria Trypaki, Vasiliki Spyrou, Manousos Christodoulakis, Elias Athanasakis, Evangelos Xynos, Maria Tzardi, Dimitrios Mavroudis, John Souglakos
    Cancers.2021; 13(14): 3522.     CrossRef
  • Effects of Helicobacter pylori Infection on the Oral Microbiota of Reflux Esophagitis Patients
    Tian Liang, Fang Liu, Lijun Liu, Zhiying Zhang, Wenxue Dong, Su Bai, Lifeng Ma, Longli Kang
    Frontiers in Cellular and Infection Microbiology.2021;[Epub]     CrossRef
  • The Association of Gut Microbiota and Complications in Gastrointestinal-Cancer Therapies
    Kevin M. Tourelle, Sebastien Boutin, Markus A. Weigand, Felix C. F. Schmitt
    Biomedicines.2021; 9(10): 1305.     CrossRef
  • Antibacterial Activity of T22, a Specific Peptidic Ligand of the Tumoral Marker CXCR4
    Naroa Serna, José Vicente Carratalá, Oscar Conchillo-Solé, Carlos Martínez-Torró, Ugutz Unzueta, Ramón Mangues, Neus Ferrer-Miralles, Xavier Daura, Esther Vázquez, Antonio Villaverde
    Pharmaceutics.2021; 13(11): 1922.     CrossRef
  • Gut Microbiota Profiles in Early- and Late-Onset Colorectal Cancer: A Potential Diagnostic Biomarker in the Future
    Murdani Abdullah, Ninik Sukartini, Saskia Aziza Nursyirwan, Rabbinu Rangga Pribadi, Hasan Maulahela, Amanda Pitarini Utari, Virly Nanda Muzellina, Agustinus Wiraatmadja, Kaka Renaldi
    Digestion.2021; 102(6): 823.     CrossRef
  • The gut microbiome in epilepsy
    Birol Şafak, Bengü Altunan, Birol Topçu, Aynur Eren Topkaya
    Microbial Pathogenesis.2020; 139: 103853.     CrossRef
  • Therapeutic Targeting of the Colorectal Tumor Stroma
    Wolf H. Fridman, Ian Miller, Catherine Sautès-Fridman, Annette T. Byrne
    Gastroenterology.2020; 158(2): 303.     CrossRef
  • Bacterial Biofilm and its Role in the Pathogenesis of Disease
    Lene K. Vestby, Torstein Grønseth, Roger Simm, Live L. Nesse
    Antibiotics.2020; 9(2): 59.     CrossRef
  • Foes or Friends? Bacteria Enriched in the Tumor Microenvironment of Colorectal Cancer
    Siyang Xu, Wen Yin, Yuling Zhang, Qimei Lv, Yijun Yang, Jin He
    Cancers.2020; 12(2): 372.     CrossRef
  • Esophageal microbiome signature in patients with Barrett’s esophagus and esophageal adenocarcinoma
    Loris Riccardo Lopetuso, Marco Severgnini, Silvia Pecere, Francesca Romana Ponziani, Ivo Boskoski, Alberto Larghi, Gianluca Quaranta, Luca Masucci, Gianluca Ianiro, Tania Camboni, Antonio Gasbarrini, Guido Costamagna, Clarissa Consolandi, Giovanni Cammaro
    PLOS ONE.2020; 15(5): e0231789.     CrossRef
  • Unsuspected clinical presentation of coronavirus disease 2019: acute bowel disease
    Marco Lotti, Michela Giulii Capponi, Dusanka Dokic, Paolo Bertoli, Alessandro Lucianetti
    ANZ Journal of Surgery.2020; 90(9): 1772.     CrossRef
  • Does Sidedness Matter in Unresectable Colorectal Cancer?
    Suneel D. Kamath, Alok A. Khorana
    Annals of Surgical Oncology.2019; 26(6): 1588.     CrossRef
  • Morphological characteristics of mucinous adenocarcinoma of the colon and its embryogenetic premises
    Yu. S. Korneva, R. V. Ukrainets
    Colorectal Oncology.2019; 9(2): 16.     CrossRef
  • Primary Tumor Sidedness Predicts Bevacizumab Benefit in Metastatic Colorectal Cancer Patients
    Xia-Hong You, Can Wen, Zi-Jin Xia, Fan Sun, Yao Li, Wei Wang, Zhou Fang, Qing-Gen Chen, Lei Zhang, Yu-Huang Jiang, Xiao-Zhong Wang, Hou-Qun Ying, Zhen Zong
    Frontiers in Oncology.2019;[Epub]     CrossRef
  • Endoscopic gastric mucosal atrophy as a predictor of colorectal polyps: a large scale case-control study
    Yoshinari Kawahara, Masaaki Kodama, Kazuhiro Mizukami, Tomoko Saito, Yuka Hirashita, Akira Sonoda, Kensuke Fukuda, Osamu Matsunari, Kazuhisa Okamoto, Ryo Ogawa, Tadayoshi Okimoto, Kazunari Murakami
    Journal of Clinical Biochemistry and Nutrition.2019; 65(2): 153.     CrossRef
  • Gut Microbiome: A Promising Biomarker for Immunotherapy in Colorectal Cancer
    Sally Temraz, Farah Nassar, Rihab Nasr, Maya Charafeddine, Deborah Mukherji, Ali Shamseddine
    International Journal of Molecular Sciences.2019; 20(17): 4155.     CrossRef
  • FirstFirst
  • PrevPrev
  • Page of 1
  • Next Next
  • Last Last

Ann Coloproctol : Annals of Coloproctology Twitter Facebook
TOP